Thu, 30 Mar 2017

COMPARATIVE BIOAVAILABILITY OF TWO LOSARTAN FORMULATIONS IN HEALTHY HUMAN VOLUNTEERS AFTER A SINGLE DOSE ADMINISTRATION

Dhaneshwar Shep1*, Dixit Patel1, Manoj Karwa2, Sanjay Maroo1, Saurabh Arora2

 

1. Medical Services, Troikaa Pharmaceuticals Ltd., Ahmedabad

2. Auriga Research Ltd., New Delhi


ABSTRACT

 

The aim of this study was to evaluate the bioequivalence of test and reference losartan potassium 50 mg formulations in healthy volunteers. This open label, balanced, single-dose, randomized, 2-period, crossover oral bioequivalence study was conducted in 54 healthy human adult subjects under fasting condition. Subjects received losartan 50 mg of either test or reference formulation with a washout period of 7 days. After study drug administration, serial blood samples were collected over a period of 48 hours. The plasma concentrations of losartan and its active metabolite were determined by a validated method using LC/MS/MS. Pharmacokinetic parameters Cmax, Tmax, t1/2, AUC0-t, AUC 0-∞, and kel, were determined for both the  formulations. The formulations were to be considered bioequivalent if the log-transformed ratios of Cmax, AUC0-t, and AUC0-∞ were within the predetermined bioequivalence range of 80% to 125%. A total of 54 subjects were enrolled. No significant differences were found based on analysis of variance.  The mean values and 90% confidence intervals (CI) of test/reference ratios for these parameters of losartan as follows: Cmax 274.90 Vs 286.93 ng/mL (83.95 -113.69); AUC0-t 434.67 Vs 438.68 ng.hr/mL (93.30 -104.03); and AUC0-∞ 463.23 Vs 464.71 ng.hr/mL (94.65 -104.80) and for its active metabolite (losartan carboxylic acid) the mean values and 90% CI of test/reference ratios for these parameters  as follows: Cmax 572.63 Vs 543.82 ng/mL (96.87-109.37); AUC0-t 3987.89 Vs 4051.07 ng.hr/mL (93.48-104.22); and AUC0-∞ 4215.58 Vs 4271.67 ng.hr/mL (94.84-105.26). This study shows that the test formulation is bioequivalent to the reference formulation for losartan and its main active metabolite.

 

Key Words: Bioequivalence, Losartan, losartan carboxylic acid, Pharmacokinetics.


[PDF]  Viewed: 3074  Downloaded: 417
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.

    Read more...

     

  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.

    Read more...

  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.

    Read more...

web counter
web counter